ARCHIVES

HPV-Positive Women Over 30 Should Be Retested Within Two Years

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

December 13, 2013

SBIR Solicitation Issued

September 13, 1996

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010